Andrographis (Andrographis paniculata) is a small annual plant native to southern Asian countries, the press release explains. It is also known askiryatain Hindi andchuan xin lianin Chinese. In Ayurveda, the dried leaves and shoots are used to treat fever, cough, bronchitis, inflammation, to name a few; in traditional Chinese medicine, it has been used as treatment for influenza, fever, cough, sore throat, and dysentery, among others.
In vitroand animal studies have found that andrographis has anti-inflammatory, antioxidant, and antimicrobial properties, according to the press release. Research has focused largely on use for respiratory and digestive conditions, and results from human clinical trials and meta-analyses suggest that andrographis may be useful in treating upper respiratory symptoms associated with cold and flu and in reducing the frequency and severity of cough.
Related: ABC: Record-Breaking Herbal Sales Predicted for 2020 Euromed Commits to Second Herb Through Adopt-an-Herb Program 5 Natural Remedies Branded Ingredients Verified Non-GMO"We are happy to be associated with ABC by adoptingAndrographis paniculata, one of the best-known medicinal plants in the Ayurvedic system for immunity and inflammation,” said Deepak Mundkinajeddu, Ph.D., Head of R&D at Natural Remedies, in the press release. “Scientific publications on this plant have risen significantly during this decade, covering various aspects such as clinical studies, mechanisms of action, and agronomy research. AP-Bio, also known as KalmCold, is derived from andrographis and is clinically tested for its immunomodulatory and anti-inflammatory properties. It is time to spread knowledge on the plant's immune health benefits as customers explore various natural immune health solutions."
The adoption will support ABC’s HerbMedPro database, which provides access to scientific and clinical research data on the uses and health effects of more than 265 herbs, spices, medicinal plants, and fungi for perusal by researchers, health professionals, industry members, students, consumers, and other members of the herbal and dietary supplement communities.
ABC’s Chief Science Officer Stefan Gafner, Ph.D., added: “We are deeply grateful to Natural Remedies for the adoption of andrographis. Data from human clinical studies support the therapeutic benefits of andrographis in patients with acute upper respiratory tract infections. The support from Natural Remedies will enable ABC to keep up with the scientific and clinical literature on andrographis in our HerbMedPro database and will make scientific information on this useful medicinal plant more easily available.”